Piedmont Investment Advisors’s Cantel Medical Corporation CMD Stock Holding History

Piedmont Investment Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,436	Closed	-$315K	–	910
2019 Q4	$315K	Sell	4,436 -461	-9%	-$33.4K	0.01%	732
2019 Q3	$366K	Sell	4,897 -126	-3%	-$10.7K	0.01%	666
2019 Q2	$405K	Buy	5,023 +1,347	+37%	+$94.7K	0.02%	638
2019 Q1	$246K	Buy	3,676 +50	+1%	+$3.79K	0.01%	942
2018 Q4	$270K	Buy	3,626 +962	+36%	+$79.4K	0.01%	787
2018 Q3	$245K	Buy	+2,664	New	+$254K	0.01%	887
2018 Q1	–	Sell	-7,326	Closed	-$754K	–	807
2017 Q4	$754K	Sell	7,326 -399	-5%	-$39.7K	0.02%	329
2017 Q3	$727K	Sell	7,725 -123	-2%	-$9.71K	0.02%	339
2017 Q2	$611K	Buy	+7,848	New	+$589K	0.01%	369

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Piedmont Investment Advisors's CMD Position: Q1 2020 in Review

Piedmont Investment Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 4,436 shares — an estimated $315K sold.

Piedmont Investment Advisors first reported a position in CMD in Q2 2017 and held it in 9 quarters. The position peaked at $754K in Q4 2017. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

Piedmont Investment Advisors reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 4,436 Cantel Medical Corporation shares in Q1 2020, an estimated $315K.
Piedmont Investment Advisors first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 9 quarters.
Piedmont Investment Advisors's Cantel Medical Corporation position peaked at $754K in Q4 2017.
213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Piedmont Investment Advisors's 13F filing for Q1 2020, filed 12 May 2020.